Granite Bay Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,505
Closed -$2.81M 77
2023
Q4
$2.81M Sell
19,505
-4,750
-20% -$693K 0.03% 147
2023
Q3
$3.56M Buy
+24,255
New +$3.56M 0.03% 135

Other funds holding ABBV

Granite Bay Wealth Management's ABBV Position: Q1 2024 in Review

Granite Bay Wealth Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 19,505 shares — an estimated $2.81M sold.

Granite Bay Wealth Management first reported a position in ABBV in Q3 2023 and held it in 2 quarters. The position peaked at $3.56M in Q3 2023. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Granite Bay Wealth Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Granite Bay Wealth Management sold 19,505 AbbVie shares in Q1 2024, an estimated $2.81M.
  • Granite Bay Wealth Management first reported a position in AbbVie in Q3 2023 and held it in 2 quarters.
  • Granite Bay Wealth Management's AbbVie position peaked at $3.56M in Q3 2023.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Granite Bay Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.